What will the obesity landscape look like in the next few years? Brooke Boyarsky Pratt, founder and CEO of knownwell, shares her thoughts on the impact of GLP-1s on Breaking Health, hosted by Michelle Snyder. Boyarsky Pratt also discusses the shifting mindset on treating obesity as a disease instead of just an issue of willpower, creating a space for obesity patients to feel comfortable seeking help, and the use of AI, as well as the impact of pivotal decisions toward company growth and lessons learned from expanding into new markets.
LINKS:
HealthEdge
McKesson Ventures
knownwell, Inc.
Breaking Health